PeptiGrowth is a supplier of innovative raw materials for the expanding market of regenerative medicine and cell and gene therapy.
We develop, manufacture and market Alternative Peptides that have the same function as growth factors in preclinical and GMP quality.
Our Alternative Peptides is manufactured by chemical synthesis method that does not use animal serum or gene recombination technology in order to achieve high purity, no variation among production lots in terms of specification, and cost reducing.
PeptiGrowth is a joint venture of Mitsubishi Corporation and PeptiDream Inc.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 2-6-1, Marunouchi, Chiyoda-Ku,tokyo 100-8086,japan
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Reagents for cell culture applications, Xeno-free, ES and iPS cells, Peptide, Growth Factor, Regenerative Medicine, Cell Therapy, Preclinical grade and GMP grade.
- HQ
- Chiyoda-ku, Tokyo
Peptigrowth Inc. Questions
Peptigrowth Inc.'s LinkedIn profile is https://jp.linkedin.com/company/peptigrowth-inc
Peptigrowth Inc. has
5 employees.
View email and phone details for 5
employees at Peptigrowth Inc..
Peptigrowth Inc.'s industry is
Biotechnology Research
Peptigrowth Inc.'s top competitors are
Xaira Therapeutics,
Milliporesigma,
Thermo Fisher Scientific,
Mitsubishi Corporation,
Stemcell Technologies,
Regeneron,
Peptidream Inc.,
Norgen Biotek,
Orizuru Therapeutics, Inc.,
Abdera Therapeutics.
Peptigrowth Inc.'s categories are Biotechnology Research
Peptigrowth Inc.'s founding year is 2020
